The effect of a restriction policy on the antimicrobial consumption in Turkey: a country-wide study

Salih Hoşoğlu1, Saban Esen, Recep Ozturk

  • 1Dicle University Hospital, Diyarbakir, 21280, Turkey. hosoglu@hotmail.com

Abstract

Insights

A new policy restricting antimicrobial prescriptions significantly reduced usage by 26.4% in Turkish hospitals. This study shows the effectiveness of infectious disease specialists in controlling antimicrobial consumption.

Area of Science:

  • Healthcare Policy
  • Infectious Disease Management
  • Pharmacoeconomics

Background:

  • Antimicrobial expenditure represented 24% of total drug spending in Turkey in 2002.
  • A government policy restricted antimicrobial prescriptions starting June 2003.
  • The policy mandated infectious disease specialists to lead antimicrobial prescribing.

Purpose of the Study:

  • To compare antimicrobial usage in Turkish hospitals before and after the policy implementation.
  • To evaluate the impact of the new prescription restriction policy on antimicrobial consumption.

Main Methods:

  • Data collected from 15 hospitals across Turkey in May and November 2003.
  • Antimicrobial usage measured in Defined Daily Doses (DDD) per 100 patient-days.
  • Consumption changes analyzed by comparing mean DDD values pre- and post-policy.

Main Results:

  • Mean antimicrobial use density decreased from 71.56 DDD/100 patient-days to 52.64 DDD/100 patient-days.
  • A statistically significant 26.4% reduction in antimicrobial usage was observed (P < 0.025).

Conclusions:

  • The implemented policy effectively reduced antimicrobial prescription rates.
  • Centralizing prescribing authority with infectious disease specialists proved successful in curbing usage.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.